Meta stock pulled back this week following a record-setting rally, but shares are finding support at their 21-day line.

A handful of biotech stocks made an elite list despite being unprofitable. But many show robust sales growth and constructive ...

A new era at IBD began nearly a year ago with the launch of MarketSurge, a makeover of the MarketSmith charting and research product that included a new brand name, new logo and a number of new ...

42,045 people played the daily Crossword recently. Can you solve it faster than others?42,045 people played the daily Crossword recently. Can you solve it faster than others? Simply Wall St. Warren ...

She believes the release of affordable EV models and autonomous driving vehicles will be catalysts for Tesla stock in 2025. In a previous interview with Yahoo Finance in November 2024 after the US ...

The expert considers that biomarkers could greatly benefit the broader inflammatory bowel disease (IBD) field if they are easy to assess and help predict clinical response. While Teva/Sanofi’s ...